Get started
Author

Tetsuhito Muranaka

Observed names: Muranaka Tetsuhito, Tetsuhito Muranaka
ORCID: 0000-0002-5146-1451
Observed ORCID: 0000-0002-5146-1451
OpenAlex ID: A5102260399
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
2017 · Tetsuhito Muranaka, Masaki Kuwatani, et al. · Journal of Gastrointestinal Oncology · 99
PDF
A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)
2017 · Michio Nakamura, Atsushi Ishiguro, et al. · The Oncologist · 49
PDF
Gastric mucosal cracked and cobblestone‐like changes resulting from proton pump inhibitor use
2016 · Shuichi Miyamoto, Mototsugu Kato, et al. · Digestive Endoscopy · 36
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer
2022 · Ken Ito, Satoshi Yuki, et al. · Supportive Care in Cancer · 13
PDF
Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer
2019 · Toshiki Masuishi, Hiroya Taniguchi, et al. · ESMO Open · 10
Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer
2017 · Takahiko Kobayashi, Junich Ishida, et al. · Tumor Biology · 9
PDF
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)
2023 · Kazuaki Harada, Takahiro Yamamura, et al. · Journal of Clinical Medicine · 8
PDF
A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)
2021 · Yasuyuki Kawamoto, Hiroshi Nakatsumi, et al. · The Oncologist · 8
PDF
Immune Checkpoint Inhibitor-Induced Colitis Successfully Followed up by Ultrasonography
2020 · Satomi Omotehara, Mutsumi Nishida, et al. · SN Comprehensive Clinical Medicine · 6
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
2017 · Yasuyuki Kawamoto, Yoshito Komatsu, et al. · BMC Cancer · 5
PDF
Self‐Directed Mikoto Simulator Training for Colonoscopy in Gastroenterology Trainees: An International Multicenter Randomized Trial
2026 · Daisuke Yamaguchi, Ryo Shimoda, et al. · Journal of Gastroenterology and Hepatology · 3
PDF
A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐ EGFR antibody: HGCSG1801
2024 · Hiroshi Nakatsumi, Yoshito Komatsu, et al. · International Journal of Cancer · 3
PDF
Predictors of the early discontinuation of anamorelin hydrochloride in gastrointestinal cancer-related cachexia: a multicenter retrospective cohort study (HGCSG2201)
2026 · Kazuaki Harada, Shinya Kajiura, et al. · Supportive Care in Cancer · 2
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
2022 · Hiroshi Nakatsumi, Yoshito Komatsu, et al. · Frontiers in Oncology · 2
PDF
Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center Experience
2016 · Tetsuhito Muranaka, Satoshi Yuki, et al. · Journal of the Korean Gastric Cancer Association · 2
PDF
HGCSG 1301: A multicenter, double-blind, randomized controlled phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer treated with IRIS/Bev as second-line therapy—Updated analysis of antitumor efficacy.
2020 · Atsushi Ishiguro, Hiroshi Nakatsumi, et al. · Journal of Clinical Oncology · 1
HGCSG 1603: Phase II study of ramucirumab and irinotecan combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer.
2019 · Atsushi Ishiguro, Yasuyuki Kawamoto, et al. · Journal of Clinical Oncology · 1
Feasibility Study of Bolus 5-Fluorouracil+L-Leucovorin as Salvage Line Chemotherapy for Oral Fluorouracil-Resistant Unresectable Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group Study HGCSG1502
2017 · Tetsuhito Muranaka, Yoshito Komatsu, et al. · Journal of Clinical Trials · 1
Phase II trial of bolus 5-FU/l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant unresectable gastric cancer (HGCSG1502).
2016 · Tetsuhito Muranaka, Satoshi Yuki, et al. · Journal of Clinical Oncology · 1
Myeloid Sarcoma with Systemic Lymphadenopathy, Skin and Gastrointestinal Infiltration
2014 · Marin Ishikawa, Takuto Miyagishima, et al. · Nihon Naika Gakkai Zasshi · 1
PDF
Diffuse large B-cell lymphoma occurring at ileocolonic anastomosis site after right hemicolectomy for colorectal cancer: a case report
2026 · Tomoya Kurose, Yuzuru Sakamoto, et al. · International Cancer Conference Journal
Ultrasonographic Diagnosis and Conservative Management of Fecal Impaction
2026 · Wahei Uemura, Tetsuhito Muranaka, et al. · Cureus
PDF
Good’s Syndrome: A Case Report
2026 · Masahiro Kishi, Tetsuhito Muranaka, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort
2025 · Goki Suda, Masaru Baba, et al. · Scientific Reports
PDF
Familial Mediterranean Fever With Compound Heterozygosity for the Pyrin Variant L110P-E148Q: A Case Report
2025 · Shuto Fukuda, Tetsuhito Muranaka, et al. · Cureus
PDF
Works count: 59
Citation count: 260
H-index: 8
I10-index: 5
Year
Topic
Type